Teri Jackson, NP
Nurse Practitioner · Rome, GANPI 1447905781
Payments from drug & device makers
Across 51 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$128
- Pfizer$103
- AbbVie$92
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$48
- Novo Nordisk$45
- Atland Pharmaceuticals, LLC$42
- plus $460 from 17 others
What the payments were for
- Food & beverage$918100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $128 |
| Pfizer | 5 | $103 |
| AbbVie | 5 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Novo Nordisk | 3 | $45 |
| Atland Pharmaceuticals, LLC | 1 | $42 |
| Bayer | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Novartis | 2 | $37 |
| Ultragenyx Pharmaceutical Inc. | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Mylan Specialty L.p. | 2 | $32 |
| Amgen | 2 | $29 |
| Aroa Biosurgery Incorporated | 1 | $29 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$918 in reported general payments places this provider in the 70th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 34 | $17,613 |
| Gabapentin | 538 | $7,957 |
| Pregabalin | 251 | $5,490 |
| Buprenorphine | 21 | $4,435 |
| Lidocaine | 32 | $3,664 |
| Diclofenac Sodium | 67 | $3,545 |
| Tizanidine Hcl | 188 | $2,087 |
| Lubiprostone | 16 | $1,918 |
| Cyclobenzaprine Hcl | 176 | $1,371 |
| Duloxetine Hcl | 84 | $1,364 |
| Tramadol Hcl | 124 | $1,301 |
| Methocarbamol | 61 | $894 |
| Zolpidem Tartrate ErZolpidem Tartrate | 12 | $579 |
| Baclofen | 60 | $503 |
| Celecoxib | 27 | $493 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rome
- Pamela AllenRome$270K
- Tricia CollinsRome$17K
- Amie GreenRome$12K
- Inga BennettRome$11K
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.